Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Pilot Study of Intranasal Oxytocin for Methamphetamine Withdrawal in Women

NCT05760807 is registered in ClinicalTrials.gov with Turning Point as lead sponsor.

NCT NCT05760807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05760807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Pilot Study of Intranasal Oxytocin for Methamphetamine Withdrawal in Women
Lead sponsor
Turning Point
Phase
Not applicable
Overall status
Completed
Start date
March 29, 2023
Completion date
March 28, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine use disorder